New report shines light on seafood fraud In 2019 alone, $2.4 billion worth of imported seafood was identified as illegal, unreported and unregulated Salon · Sep 22, 2022
Lawmakers strike deal on FDA user fee bill WASHINGTON — Senate committee leaders have struck an agreement to reauthorize five-year user fee deals for the Food and Drug Administration, although details of a broader stopgap government spending bill remain unfinished. Tribune News Service · Sep 22, 2022
Lawmakers strike deal on 'practically clean' FDA user fee bill - Roll Call The reauthorization is expected to hitch a ride on the short-term government funding bill Congress is expected to take up next week. Roll Call · Sep 22, 2022
Warning over dangerous 'sleepy chicken' social media challenge using cough medicine Known as the "sleepy chicken" challenge, health chiefs have warned that the viral trend is dangerous and could even cause death. Daily Record · Sep 22, 2022
Breast cancer risk due to implants explained as FDA warns about potential link Breast cancer and breast implants link has been shrouded with anecdotal doubts and theories. Recently, the Food and Drug Administration has issued a statement pertaining to this Daily Mirror · Sep 22, 2022
Please don't cook chicken in NyQuil, the FDA asks TikTok users The challenge, which originated in part from a 2017 Twitter joke, is the subject of an FDA warning about unhealthy cooking challenges from TikTok. WEKU · Sep 22, 2022
FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ TikTok trend resurfaces ‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said The Independent UK · Sep 22, 2022
Food industry wary of mandates ahead of hunger conference WASHINGTON — The food industry is hoping that changes in its market in the past five decades will persuade the Biden administration and Congress to tread lightly as they consider new mandates on the sector. Tribune News Service · Sep 21, 2022
'This Is Not a Bluff': Putin Amps Up Nuke Threats Plus: Migrants sue DeSantis, Justice Department undercounts jail and prison deaths, Juul sues for FDA records, and more... Reason · Sep 21, 2022
Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More.. Wall Street Journal Benzinga · Sep 21, 2022
IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.” Benzinga · Sep 21, 2022
Food industry wary of mandates ahead of hunger conference - Roll Call As the administration prepares for its Sept. 28 hunger conference, the food industry is wary of new labeling mandates. Roll Call · Sep 21, 2022
FDA seems poised to approve a new drug for ALS, but does it work? In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway. WEKU · Sep 21, 2022
FDA warns cooks about "NyQuil Chicken" TikTok users are apparently bringing to cold and flu medicine into the kitchen, with potentially poisonous results Salon · Sep 21, 2022
The Independent UK · Sep 20, 2022 Don’t cook your chicken in Nyquil, FDA warns after viral social media trend resurfaces “These video challenges, which often target youths, can harm people — and even cause death,” the agency said.
The Independent UK · Sep 20, 2022 FDA concedes delays in response to baby formula shortage U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory
Benzinga · Sep 20, 2022 FDA Says No Way To Food Companies Wanting To Get On The CBD Gravy Train As several major food makers are champing at the bit to cash in on the CBD food and drinks craze, it seems the FDA is still not down with the program.
StockNews.com · Sep 20, 2022 3 Healthcare Stocks Under $100 to Buy Right Now The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…
Benzinga · Sep 20, 2022 Dow Dips 400 Points; Ford Shares Slide U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.
Benzinga · Sep 20, 2022 Nasdaq Down 50 Points; Crude Oil Falls Sharply U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.
WEKU · Sep 19, 2022 Family Dollar recalls Colgate products that were improperly stored Family Dollar says it is not aware of any complaints from customers nor any reports of illnesses related to the recall.
Tribune News Service · Sep 17, 2022 Bluebird’s gene therapy for brain disease receives accelerated approval Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment of its kind for children living with cerebral adrenoleukodystrophy.
Benzinga · Sep 17, 2022 FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.